Market Tracker

04/28 5:16pm ET

AstraZeneca PLC (NYSE:AZN)

30.25
Delayed Data
As of Apr 28
 -0.61 / -1.98%
Today’s Change
25.55
Today|||52-Week Range
35.04
+10.72%
Year-to-Date
AstraZeneca (AZN) Q1 Earnings Beat, Revenues Meet Estimates
Apr 28 / Zacks.com - Paid Partner Content
Making Sense of Thursday's Flood of Biotech and Pharma Earnings Reports
Apr 27 / TheStreet.com - Paid Partner Content
Frontrunning: April 28
Apr 28 / Investing Channel - Paid Partner Content
AstraZeneca Tops Earnings Estimate, But Crestor and Onglyza Sales Slow
Apr 27 / TheStreet.com - Paid Partner Content
Wetherby Asset Management Inc Buys Enbridge, Nippon Telegraph & Telephone, Abbott ...
Apr 27 / GuruFocus News - Paid Partner Content
AbbVie's (ABBV) Cancer Candidate Fails in Phase III Studies
Apr 20 / Zacks.com - Paid Partner Content
First Bank & Trust Buys Dominion Resources, Total SA, SBA Communications, Sells The K...
Apr 27 / GuruFocus News - Paid Partner Content
 

Today’s Trading

Previous close30.86
Today’s open30.58
Day’s range30.21 - 30.65
Volume4,930,517
Average volume (3 months)5,575,931
Market cap$76.6B
Dividend yield4.63%
Data as of 4:03pm ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)+23.59%
Earnings growth (this year)-13.81%
Earnings growth (next 5 years)+0.33%
Revenue growth (last year)-7.37%
P/E ratio21.9
Price/Sales3.03
Price/Book5.10

Competitors

 Today’s
change
Today’s
% change
ABTAbbott Laboratories-0.01-0.02%
NVONovo Nordisk-0.10-0.26%
AGNAllergan+0.81+0.33%
LLYEli Lilly and Co+0.73+0.90%
Data as of 4:03pm ET, 04/28/2017

Financials

Next reporting dateJuly 27, 2017
EPS forecast (this quarter)$0.43
Annual revenue (last year)$22.8B
Annual profit (last year)$3.5B
Net profit margin15.21%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Pascal Soriot
Executive VP-Operations &
Information Technology
Pam P. Cheng
Corporate headquarters
London, Greater London

Forecasts